This second webinar will present the challenges and the state-of-the-art empirical science of CDoH, focussing on how health communities, governments and business can approach measurement in CDoH. It will also present approaches reorient financial indicators towards health, wellbeing, and equity.

One of the key priorities identified for WHO is the need to raise awareness and understanding of the commercial determinants of health, their impact, and effective action for policymakers to address them. Therefore, WHO has launched a series of webinars for a diverse audience that will explore the evidence base for commercial determinants of health, how they manifest in practice, and potential actions at different levels and by different actors. [1.44 hours]

Agenda: Welcome and introductions: Etienne Krug, Director, Social Determinants of Health, WHO and Stephen MacFeely, Director of Data and Analytics, WHO

Keynote presentation: Kelley Lee, Professor of Public Health, Simon Fraser University, Canada

Roundtable:

• Monika Arora, Professor; Director Health Promotion Division, Public Health Foundation of India; President-elect NCD Alliance
• Tonatiuh Barrientos (Gutierrez), Senior Researcher, National Institute of Public Health, Mexico
• Neena Prasad, Director, Bloomberg Philanthropies Obesity Prevention Programme
• Meg Jones-Monteiro, Program Director, Health Equity, Interfaith Center on Corporate Responsibility
• Theo Vos, Professor, Institute for Health Metrics and Evaluation (IHME)

Webinar Chair and Moderator: Rob Moodie, Professor, Melbourne School of Population and Global Health

Conclusions and close: Monika Kosinska, Head, Economic and Commercial Determinants, WHO

[See also, Webinar 1: 7 December 2021 - Commercial determinants of health: What are they? Why do they matter? What can we do?]